Journey MedicalDERM +6.43%62 Days Inventory is 138.80 as of Mar. 2026, which is 3% below its 10-year median of 142.45. GuruFocus rates DERM with a GF Score™ of 62/100 and a GF Value™ of $4.17 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 919 Drug Manufacturers companies, Journey Medical ranks worse than 58.11% on this metric.
The historical rank and industry rank for Journey Medical's Days Inventory or its related term are showing as below:
DERM'
s Days Inventory Range Over the Past 10 Years
Min: 28.27 Med: 142.45 Max: 215.35
Current: 183.16
During the past 7 years, Journey Medical's highest Days Inventory was 215.35. The lowest was 28.27. And the median was 142.45.
DERM's Days Inventory is ranked worse than 58.11% of 919
companies
in the Drug Manufacturers industry
Industry Median: 162.83
vs DERM: 183.16
Journey Medical's Days Inventory
declined
from Mar. 2025 (256.48) to Mar. 2026 (138.80).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Journey Medical's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.66.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Journey Medical's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.59.
Journey Medical (NAS:DERM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Journey Medical's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Journey Medical's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Journey Medical Days Inventory Related Terms
Journey Medical Days Inventory Historical Data
* Premium members only.
The historical data trend for Journey Medical's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DERM vs LFCR, ANIK, ASRT: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Journey Medical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Journey Medical Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Journey Medical's Days Inventory distribution charts can be found below:
* The bar in red indicates where Journey Medical's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Journey Medical (DERM) has a Days Inventory of 138.80 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Journey Medical and its competitors. This is near median its historical median of 142.45. Over the past decade, Journey Medical's Days Inventory has ranged from 28.27 to 215.35. According to the industry distribution chart, Journey Medical ranks #534 out of 919 companies in the Drug Manufacturers industry, placing it in the top 58.1%.
Is Journey Medical's Days Inventory too high?
Journey Medical's current Days Inventory of 138.80 is near median its 10-year median of 142.45. Over the past 10 years, this metric has ranged from a low of 28.27 to a high of 215.35. The Drug Manufacturers industry median Days Inventory is 162.83. Journey Medical's value of 138.80 is 14.8% below this industry median. Based on the distribution chart, Journey Medical ranks #534 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Journey Medical has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Journey Medical's Days Inventory compare to LFCR and ANIK?
According to the Drug Manufacturers industry distribution chart, Journey Medical ranks #534 out of 919 companies for Days Inventory. This places Journey Medical in the lower half of its industry. The industry median Days Inventory is 162.83. Journey Medical's value of 138.80 is 14.8% below this benchmark. Historically, Journey Medical's own Days Inventory has ranged from 28.27 to 215.35 over the past decade. While the company's 10-year median is 142.45 vs. the industry median of 162.83, Journey Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 162.83, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Journey Medical's current Days Inventory of 138.80 is 14.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Journey Medical and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 162.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Journey Medical's current Days Inventory is 138.80, which is near median its own 10-year median of 142.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Journey Medical stock overvalued right now?
Based on GuruFocus' analysis, Journey Medical (DERM) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.17, compared to a current price of $6.62 — trading 58.8% above its estimated fair value. The current Days Inventory is 138.80, which is near median its 10-year median of 142.45 and 14.8% below the Drug Manufacturers industry median of 162.83. Journey Medical's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Journey Medical (DERM), the current Days Inventory is 138.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Journey Medical (DERM) Overvalued in 2026?
Based on GuruFocus' analysis, Journey Medical stock appears to be overvalued.
The current stock price of $6.62 is trading 58.8% above its estimated GF Value™ of $4.17.
GuruFocus considers Journey Medical to be Significantly Overvalued.
Key valuation signals for DERM:
Days Inventory: 138.80 (near median its 10-year median of 142.45)
GF Value™: $4.17 vs. price of $6.62 (58.8% above fair value)
Industry Position: 14.8% below the Drug Manufacturers median (#534 of 919)
No single metric tells the full story. See the DERM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
62GF Score
Get the complete analysis for DERM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DERM has been successfully added to your 
